Share this NATF page   

Dr. Goldhaber

May 2017 President's Letter

We had our most successful ever Spring Patient Program.

We covered new topics that had not previously been discussed in our NATF live symposia.  The evening started with Enrico Cagliero, MD, who provided us with details on the epidemic of diabetes and metabolic syndrome.  He pointed out that these conditions predispose to thrombotic illness.

Christian Ruff, MD, MPH, spoke about a panel of readily available blood tests that can predict the likelihood of future myocardial infarction and stroke.  He and his colleagues are working on a panel of these blood tests that would be accessible by any Primary Care Provider and that would be relatively inexpensive.

Paul Ridker, MD, MPH, who last week published two first-authored articles in the New England Journal of Medicine, explained to us the new generation of potent medications which can reduce total cholesterol and
“bad” LDL cholesterol to unprecedented low levels.

Finally, Calum MacRae, MD, PhD, Chief of the BWH Cardiovascular Division, told us about the grant he was awarded to conquer coronary artery disease.  In a 250-word grant application, he explained the rationale for his innovative vision and received $75 million to fund this research.

The formal part of the program was followed by an elegant dinner where symposium participants and faculty were able to chat informally and mingle.

In collaboration with “Thrombosis TV,” we will post edited video of the scientific presentations on our NATF website.

Respectfully submitted,

 

Samuel Z. Goldhaber, MD

President, NATF

About NATF

Patients

Professionals

Events


Membership

Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120


NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum


Web Development by MTC